No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs35453500 |
chr12:85430187-85430188 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs558510967 |
chr12:85430191-85430192 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs151078141 |
chr12:85430203-85430204 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs541325395 |
chr12:85430213-85430214 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs558146259 |
chr12:85430224-85430225 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs557911832 |
chr12:85430300-85430301 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs575169961 |
chr12:85430302-85430303 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs574703469 |
chr12:85430307-85430308 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs74873900 |
chr12:85430344-85430345 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs111331871 |
chr12:85430365-85430366 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs563262107 |
chr12:85430382-85430383 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs530606617 |
chr12:85430417-85430418 |
Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs141124483 |
chr12:85430444-85430445 |
Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs370602703 |
chr12:85430445-85430446 |
Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs112776838 |
chr12:85430458-85430459 |
Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs5799718 |
chr12:85430526-85430527 |
Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs543889514 |
chr12:85430531-85430532 |
Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs398044606 |
chr12:85430536-85430537 |
Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs150268836 |
chr12:85430684-85430685 |
Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs75142967 |
chr12:85430711-85430712 |
Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs528044888 |
chr12:85430812-85430813 |
Active TSS Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs144911106 |
chr12:85430820-85430821 |
Active TSS Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs73379726 |
chr12:85430864-85430865 |
Active TSS Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
24 |
rs190736478 |
chr12:85430951-85430952 |
Active TSS Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs148274577 |
chr12:85430952-85430953 |
Active TSS Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs56897633 |
chr12:85430953-85430954 |
Active TSS Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs550727306 |
chr12:85430958-85430959 |
Active TSS Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs374823668 |
chr12:85431023-85431024 |
Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs181669101 |
chr12:85431027-85431028 |
Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs537545506 |
chr12:85431028-85431029 |
Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs184400648 |
chr12:85431045-85431046 |
Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs570516699 |
chr12:85431058-85431059 |
Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs534660892 |
chr12:85431065-85431066 |
Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs189158447 |
chr12:85431068-85431069 |
Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs369099965 |
chr12:85431071-85431072 |
Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs575049911 |
chr12:85431091-85431092 |
Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs373063056 |
chr12:85431157-85431158 |
Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs181084038 |
chr12:85431158-85431159 |
Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs560055021 |
chr12:85431170-85431171 |
Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs185735419 |
chr12:85431182-85431183 |
Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs575291959 |
chr12:85431194-85431195 |
Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs545917573 |
chr12:85431201-85431202 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs564127833 |
chr12:85431217-85431218 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs548599366 |
chr12:85431270-85431271 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs528107816 |
chr12:85431271-85431272 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs544105827 |
chr12:85431290-85431291 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs140779921 |
chr12:85431351-85431352 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs554304647 |
chr12:85431424-85431425 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs115869572 |
chr12:85431534-85431535 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs144584863 |
chr12:85431555-85431556 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|